Legislation to increases access to PrEP, PEP passes out of Illinois Senate committee

On March 23, HB4430: Increasing Access to PrEP & PEP Through Community Pharmacies was passed by the Senate Executive Committee on a bipartisan vote of 14-2.

Sponsored by State Sen. Mike Simmons (D-Chicago) and State Rep. Kelly M. Cassidy (D-Chicago), HB4430 is making its way through the legislative process.

Earlier this month, HB4430 passed out of the Illinois House of Representatives with a bipartisan vote of 71-24.  HB4430 will next be called on the Senate floor for a vote.

HB 4430 would allow Illinois pharmacists to administer and dispense HIV prevention medications, PrEP and PEP, under a standing order of a licensed physician.

The bill is sponsored by State Sen. Mike Simmons (D-Chicago) and State Rep. Kelly M. Cassidy (D-Chicago) and backed by the AIDS Foundation Chicago (AFC), Illinois Pharmacists Association, Howard Brown Health, Equality Illinois, the Illinois Retail Merchants Association

AFC said in a blog post that people living with or impacted by HIV, especially Black, Latinx and LGBTQ individuals, are faced with various barriers like accessing proper healthcare, discrimination and medical mistrust. The bill would help expand and improve access for marginalized communities.

As we enter the last two weeks of the legislative session, we need your help to get HB4430 across the finish line! With your help, we can expand access to PrEP and PEP and advance the state plan to end the HIV epidemic in Illinois by connecting those who would most benefit from PrEP and PEP services to HIV preventative care.

The AFC is asking for people to contact their legislators to support the bill. You can email or tweet your state legislators using our Action center found here.

Know a useful resource?

Share it with your community!

We aggregate links that connect to resources across Illinois. If you know of a site that should be included or want your website listed, please submit it!

This site uses cookies to provide you with a great user experience. By continuing to use this website, you consent to the use of cookies in accordance with our privacy policy.

Scroll to Top